Determination of donepezil in human plasma by HPLC-MS.
- Author:
Yi-hong LU
1
;
Hong-mei WEN
;
Wei LI
;
Yu-mei CHI
;
Zheng-xing ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Cholinesterase Inhibitors; blood; pharmacokinetics; Chromatography, High Pressure Liquid; methods; Humans; Indans; blood; pharmacokinetics; Mass Spectrometry; methods; Piperidines; blood; pharmacokinetics; Spectrometry, Mass, Electrospray Ionization
- From: Acta Pharmaceutica Sinica 2003;38(3):203-206
- CountryChina
- Language:Chinese
-
Abstract:
AIMTo establish a sensitive and specific liquid chromatography-mass spectrometry (time-of-flight) [LC-MS (TOF)] method for the determination of donepezil in human plasma after an oral administration of 5 mg donepezil hydrochloride tablet.
METHODSAlkalized plasma was extracted with isopropanol-n-hexane (3:97) and loratadine was used as internal standard. Solutes were separated on a C18 column with a mobile phase of methanol-acetate buffer (pH 4.0) (80:20). Detection was performed on a time-of-flight mass spectrometry equipped with an ESI interface and operated in positive-ionization mode. Donepezil quantitation was realized by computing the peak area ratio (donepezil-loratadine) (donepezil m/z 380[M + H]+ and loratadine m/z 383[M + H]+) and comparing them with calibration curve (r = 0.9998).
RESULTSThe linear calibration curve was obtained in the concentration range of 0.1-15 micrograms.L-1. The detection limit of donepezil was 0.1 microgram.L-1. The average recovery was more than 90%. The intra- and inter-run precision was measured to be below 15% of RSD.
CONCLUSIONThe method is sensitive, simple and rapid, so, it can meet the need of the studies on the pharmacokinetics and bioavailability of donepezil.